Septerna, INC. (SEPN) — SEC Filings

Overview

Septerna, INC. (SEPN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Apr 17, 2026: On April 17, 2026, Septerna, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions that occurred on April 15, 2026. The reporting person is Elizabeth Bhatt, associated with Septerna, Inc.

Sentiment Summary

Across 27 filings, the sentiment breakdown is: 1 bearish, 25 neutral, 1 mixed. The dominant filing sentiment for Septerna, INC. is neutral.

Filing Type Overview

Septerna, INC. (SEPN) has filed 1 4, 15 8-K, 4 10-Q, 1 DEF 14A, 1 10-K, 1 SC 13D, 1 SC 13G, 2 S-1/A, 1 S-1 with the SEC between Oct 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (27)

• Septerna, Inc. Files Form 4 for Ownership Changes — 4 · Apr 17, 2026 Risk: low
  On April 17, 2026, Septerna, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions that occurred on Apri
• 8-K Filing — 8-K · Apr 13, 2026
• Septerna Swings to Profit on Revenue Surge, Asset Sale — 10-Q · Nov 10, 2025 Risk: medium
  Septerna, Inc. reported a significant financial turnaround for the three months ended September 30, 2025, achieving a net income of $8.173 million, a substantia
• Septerna, Inc. Files 8-K on Officer/Director Changes — 8-K · Sep 29, 2025 Risk: medium
  On September 25, 2025, Septerna, Inc. filed an 8-K report detailing the departure of directors or certain officers, the election of directors, the appointment o
• Septerna, Inc. Files 8-K Report — 8-K · Sep 3, 2025 Risk: low
  On September 3, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits.
• Septerna, Inc. Files 8-K Report — 8-K · Aug 21, 2025 Risk: low
  On August 21, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specifi
• Septerna's Q2 Loss Widens to $35.6M Amid R&D Ramp-Up — 10-Q · Aug 11, 2025 Risk: high
  Septerna, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company remains in the clini
• Septerna, Inc. Announces Board and Executive Compensation Changes — 8-K · Aug 4, 2025 Risk: low
  On July 30, 2025, Septerna, Inc. announced changes to its board of directors and executive compensation. Specifically, the company reported the departure of a d
• Septerna, Inc. Files 8-K Report — 8-K · Jul 2, 2025 Risk: low
  On July 1, 2025, Septerna, Inc. filed an 8-K report to disclose other events. The company, incorporated in Delaware with its principal executive offices in Sout
• Septerna, Inc. Files 8-K on Security Holder Vote Matters — 8-K · Jun 18, 2025 Risk: low
  On June 17, 2025, Septerna, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware wit
• Septerna, Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: medium
  Septerna, Inc. filed its 10-Q for the period ending March 31, 2025. The company's fiscal year ends on December 31st. Key dates include the IPO on October 28, 20
• Septerna, Inc. Files 8-K for Material Definitive Agreement — 8-K · May 14, 2025 Risk: medium
  On May 13, 2025, Septerna, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Sout
• Septerna Inc. Files Definitive Proxy Statement for 2025 Shareholder Meeting — DEF 14A · Apr 29, 2025 Risk: low
  Septerna, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 17, 2025. The company, incorporated in Delaware with its p
• Septerna, Inc. Files 8-K on Financials — 8-K · Mar 27, 2025 Risk: low
  On March 27, 2025, Septerna, Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial
• 10-K Filing — 10-K · Mar 27, 2025
• Septerna, Inc. Files 8-K Report — 8-K · Mar 3, 2025 Risk: low
  On March 3, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhib
• Septerna, Inc. Files 8-K Report — 8-K · Feb 18, 2025 Risk: low
  On February 18, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and E
• Septerna, Inc. Files 8-K Report — 8-K · Jan 13, 2025 Risk: low
  On January 13, 2025, Septerna, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specif
• Septerna, Inc. Files 8-K: Board & Executive Compensation Updates — 8-K · Jan 6, 2025 Risk: medium
  On December 6, 2024, Septerna, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes information
• Septerna, Inc. Files 8-K on Financials — 8-K · Nov 20, 2024 Risk: low
  On November 20, 2024, Septerna, Inc. filed an 8-K report. The filing indicates that the company is providing information regarding its results of operations and
• Septerna, Inc. Files Q3 2024 10-Q — 10-Q · Nov 20, 2024 Risk: medium
  Septerna, Inc. filed its 10-Q for the period ending September 30, 2024. The company, focused on pharmaceutical preparations, reported financial data for Q3 2024
• RA Capital Discloses 14.9% Stake in Septerna, Inc. — SC 13D · Nov 4, 2024 Risk: medium
  On November 4, 2024, RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., filed a Schedule 13D. They
• SC 13G Filing — SC 13G · Nov 1, 2024
• Septerna, Inc. Files 8-K for Corporate Updates — 8-K · Oct 28, 2024 Risk: low
  On October 28, 2024, Septerna, Inc. filed an 8-K report. The filing primarily concerns amendments to its Articles of Incorporation or Bylaws and the submission
• Septerna, Inc. Files S-1/A for IPO — S-1/A · Oct 24, 2024 Risk: medium
  Septerna, Inc. filed an S-1/A amendment on October 24, 2024, for its initial public offering. The company, incorporated in Delaware, is seeking to register its
• Septerna, Inc. Files S-1/A Amendment — S-1/A · Oct 21, 2024 Risk: medium
  Septerna, Inc. filed an S-1/A amendment on October 21, 2024, to its registration statement. The company, incorporated in Delaware with its principal executive o
• Septerna, Inc. Files for IPO — S-1 · Oct 2, 2024 Risk: medium
  Septerna, Inc., a biopharmaceutical company, filed an S-1 registration statement on October 2, 2024, to offer its securities. The company is based in South San

Related Companies

NVO · SPRT

Frequently Asked Questions